Literature DB >> 24430301

Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells.

Qinghua Li1, Lihong Mao, Ruili Wang, Liqiang Zhu, Lexun Xue.   

Abstract

S-adenosylhomocysteine hydrolase (SAHH) is the sole enzyme that catalyses the hydrolysis of S-adenosylhomocysteine (SAH) in methylation reaction. Previous studies have shown that its inhibition or deficiency leads to several human disorders such as severe coagulopathy, hepatopathy and myopathy. However, the effects of SAHH on esophageal squamous cell carcinoma (ESCC) cells have not been explored so far. To determine whether SAHH is involved in carcinogenesis of the esophagus, we investigated the expression of SAHH in ESCC and normal esophageal epithelial cells and found that SAHH was downregulated in ESCC cells compared with normal esophageal epithelial cells (P < 0.05). The overexpressed SAHH in ESCC cells promoted cell apoptosis, inhibited cell migration and adhesion, but did not affect the cell proliferation and cell cycle. Furthermore, an interaction of SAHH with receptor of activated C kinase 1 (RACK1) protein was detected by coimmunoprecipitation and an increased RACK1, which is caused by overexpression of SAHH, was verified by Western blotting. The findings mentioned above demonstrate that SAHH can promote apoptosis, inhibit migration and adhesion of ESCC cells suggesting that it may be involved in carcinogenesis of the esophagus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430301     DOI: 10.1007/s11033-014-3095-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  22 in total

1.  Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells.

Authors:  Lili Wang; Guiqin Hou; Lexun Xue; Jie Li; Pan Wei; Peirong Xu
Journal:  Cancer Invest       Date:  2010-05-26       Impact factor: 2.176

2.  [The relationship between RACK1 expression and clinicopathologic information of esophageal squamous cell carcinoma].

Authors:  Zhong-yue Wang; Zhao-li Chen; Min Feng; Su-sheng Shi; Jie He; Guang-hai Dai
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2011-05-31

3.  RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway.

Authors:  Shuo Shi; Yue-Zhen Deng; Jiang-Sha Zhao; Xiao-Dan Ji; Jun Shi; Yu-Xiong Feng; Guo Li; Jing-Jing Li; Di Zhu; H Phillip Koeffler; Yun Zhao; Dong Xie
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

4.  Downregulation of receptor for activated C-kinase 1 (RACK1) suppresses tumor growth by inhibiting tumor cell proliferation and tumor-associated angiogenesis.

Authors:  Feng Wang; Tsuyoshi Osawa; Rika Tsuchida; Yasuhito Yuasa; Masabumi Shibuya
Journal:  Cancer Sci       Date:  2011-09-22       Impact factor: 6.716

5.  S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition.

Authors:  Annette Hayden; Peter W M Johnson; Graham Packham; Simon J Crabb
Journal:  Breast Cancer Res Treat       Date:  2010-06-17       Impact factor: 4.872

6.  Adenosine-mediated killing of cultured epithelial cancer cells.

Authors:  C P Barry; S E Lind
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

7.  Role of S-adenosylhomocysteine hydrolase in adenosine-induced apoptosis in HepG2 cells.

Authors:  Marina Hermes; Hartmut Osswald; Doris Kloor
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

8.  Crystal structure of S-adenosyl-L-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum.

Authors:  Nobutada Tanaka; Masayuki Nakanishi; Yoshio Kusakabe; Katsura Shiraiwa; Saori Yabe; Yasutomo Ito; Yukio Kitade; Kazuo T Nakamura
Journal:  J Mol Biol       Date:  2004-10-29       Impact factor: 5.469

9.  Clinical picture of S-adenosylhomocysteine hydrolase deficiency resembles phosphomannomutase 2 deficiency.

Authors:  Tomáš Honzík; Martin Magner; Jakub Krijt; Jitka Sokolová; Oliver Vugrek; Robert Belužić; Ivo Barić; Hana Hansíkova; Milan Elleder; Kateřina Veselá; Lenka Bauerová; Nina Ondrušková; Pavel Ješina; Jiří Zeman; Viktor Kožich
Journal:  Mol Genet Metab       Date:  2012-08-23       Impact factor: 4.797

Review 10.  [S-adenosyl-L-homocysteine hydrolase as an attractive target for antimicrobial drugs].

Authors:  Masayuki Nakanishi
Journal:  Yakugaku Zasshi       Date:  2007-06       Impact factor: 0.302

View more
  7 in total

1.  Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment.

Authors:  Julia Krushkal; Yingdong Zhao; Curtis Hose; Anne Monks; James H Doroshow; Richard Simon
Journal:  Clin Epigenetics       Date:  2016-06-24       Impact factor: 6.551

2.  Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model.

Authors:  Chidimma Agatha Akpa; Karsten Kleo; Elisabeth Oker; Nancy Tomaszewski; Clemens Messerschmidt; Cristina López; Rabea Wagener; Kathrin Oehl-Huber; Katja Dettmer; Anne Schoeler; Dido Lenze; Peter J Oefner; Dieter Beule; Reiner Siebert; David Capper; Lora Dimitrova; Michael Hummel
Journal:  BMC Cancer       Date:  2020-05-14       Impact factor: 4.430

3.  S-adenosyl-l-homocysteine hydrolase links methionine metabolism to the circadian clock and chromatin remodeling.

Authors:  Carolina Magdalen Greco; Marlene Cervantes; Jean-Michel Fustin; Kakeru Ito; Nicholas Ceglia; Muntaha Samad; Jiejun Shi; Kevin Brian Koronowski; Ignasi Forne; Suman Ranjit; Jonathan Gaucher; Kenichiro Kinouchi; Rika Kojima; Enrico Gratton; Wei Li; Pierre Baldi; Axel Imhof; Hitoshi Okamura; Paolo Sassone-Corsi
Journal:  Sci Adv       Date:  2020-12-16       Impact factor: 14.136

4.  Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer.

Authors:  Katsutaka Mitachi; Kyohei Ariake; Hiroki Shima; Satoko Sato; Takayuki Miura; Shimpei Maeda; Masaharu Ishida; Masamichi Mizuma; Hideo Ohtsuka; Takashi Kamei; Kazuhiko Igarashi; Michiaki Unno
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

5.  Screening and cellular validation of prognostic genes regulated by super enhancers in oral squamous cell carcinoma.

Authors:  Liru Zhang; Huanju Li; Yongle Qiu; Yuanhang Liu; Xin Liu; Wenjing Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  A combined proteomics and metabolomics approach to assess the effects of gold nanoparticles in vitro.

Authors:  Sabrina Gioria; Joana Lobo Vicente; Paola Barboro; Rita La Spina; Giorgio Tomasi; Patricia Urbán; Agnieszka Kinsner-Ovaskainen; Rossi François; Hubert Chassaigne
Journal:  Nanotoxicology       Date:  2016-02-10       Impact factor: 5.913

7.  Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest.

Authors:  Lucija Belužić; Ivana Grbeša; Robert Belužić; Jong Hoon Park; Hyun Kyung Kong; Nevenka Kopjar; Guadalupe Espadas; Eduard Sabidó; Adriana Lepur; Filip Rokić; Ivanka Jerić; Lidija Brkljačić; Oliver Vugrek
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.